StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) stock

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.20+0.09 (+0.47%)

Close on Nov 17, 2026Market cap $625.57MP/E –Yield 0.00%

Nuvectis Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Nuvectis Pharma

Nuvectis Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nuvectis Pharma figures

See a number that looks wrong?